SM
BEAT

SG3 Management’s BioTelemetry, Inc. BEAT Stock Holding History

SG3 Management’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-12,300
Closed -$561K – 1320
2020
Q3 		$561K Buy
+12,300
New +$514K 0.02% 538
2019
Q2 		– Sell
-30,000
Closed -$1.88M – 573
2019
Q1 		$1.88M Buy
+30,000
New +$2.06M 0.19% 109

Other funds holding BEAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
GL
Governors Lane New York $1.56B AUM 30.42% 1-Year Est. Return
SGCM
Sand Grove Capital Management London, United Kingdom $444M AUM 131.11% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

SG3 Management's BEAT Position: Q4 2020 in Review

SG3 Management sold out of BioTelemetry, Inc. (BEAT) in Q4 2020, closing a stake of 2,700 shares — an estimated $123K sold.

SG3 Management first reported a position in BEAT in Q3 2020 and held it in 1 quarter. The position peaked at $123K in Q3 2020. 238 funds tracked by Wall St. Rank hold BEAT as of Q4 2020.

  • SG3 Management reported no remaining BioTelemetry, Inc. position as of Q4 2020 after selling out during the quarter.
  • SG3 Management sold 2,700 BioTelemetry, Inc. shares in Q4 2020, an estimated $123K.
  • SG3 Management first reported a position in BioTelemetry, Inc. in Q3 2020 and held it in 1 quarter.
  • SG3 Management's BioTelemetry, Inc. position peaked at $123K in Q3 2020.
  • 238 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q4 2020.

Based on SG3 Management's 13F filing for Q4 2020, filed 16 Feb 2021.